시장보고서
상품코드
1954235

헬스케어 및 생명과학용 자연언어처리(NLP) 시장 분석 및 예측(-2035년) : 유형별, 제품별, 서비스별, 기술별, 구성 요소별, 용도별, 배포별, 최종 사용자별, 기능별

NLP in Healthcare and Life Sciences Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Deployment, End User, Functionality

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 377 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

헬스케어 및 생명과학용 자연언어처리 시장은 2024년의 41억 달러에서 2034년까지 395억 달러로 확대되어 CAGR 약 27.1%를 나타낼 것으로 예측됩니다. 헬스케어 및 생명과학용 자연언어처리 시장은 복잡한 의료 데이터의 분석 및 해석에 자연언어처리 기술을 적용하는 영역을 말합니다. 여기에는 환자 기록, 임상시험 데이터, 과학 문헌 등이 포함됩니다. NLP는 효율적인 데이터 추출과 지식 획득을 가능하게 함으로써 의사결정의 정확성 향상, 환자 결과 개선, 연구 진전에 기여합니다. 디지털화의 진전과 맞춤형 의료에 대한 수요가 높아지는 가운데, 데이터 상호 운용성이나 AI 구동형 진단 기술에 있어서의 혁신이 시장 성장을 견인하고 있습니다.

헬스케어 및 생명과학용 자연언어처리 시장은 첨단 데이터 분석과 환자 관리의 필요성으로 빠르게 확대되고 있습니다. 소프트웨어 부문이 주도적이며 임상 텍스트 마이닝 및 전자 의료 기록(EHR) 데이터 분석은 의료 제공 개선에 매우 중요합니다. 이러한 애플리케이션은 정밀한 환자 진단과 맞춤 치료 계획을 가능하게 합니다. 서비스 부문이 이어지고, 특히 컨설팅 및 통합 서비스가 두드러지며 의료 시스템에서 NLP 기술 도입의 복잡성을 반영합니다. 자동 문자 발생 및 환자 모니터링과 같은 임상 애플리케이션은 운영 효율성을 크게 향상시키는 최상위 하위 부문입니다. 의약품과 유전체 분석은 R&D 프로세스의 가속화 요구에 힘입어 다음과 같은 하위 부문으로 부상하고 있습니다. 실시간 데이터 처리와 의사결정을 위한 NLP 도입이 기세를 늘리고 이해관계자에게 유리한 기회를 제공합니다. AI 중심 의료 솔루션에 대한 투자가 증가하고 있으며, 신뢰와 보급 촉진에 있어서의 데이터 프라이버시와 규제 준수의 중요성이 강조되고 있습니다.

시장 세분화
유형 규칙 기반 NLP, 통계 NLP, 하이브리드 NLP, 딥러닝 NLP
제품 소프트웨어, 플랫폼, 도구, 애플리케이션
서비스 컨설팅, 구현, 교육, 지원 및 유지보수
기술 머신러닝, 딥러닝, 컨텍스트 인식 컴퓨팅, 컴퓨터 비전
구성요소 솔루션, 서비스
용도 임상 문서, 컴퓨터 지원 코딩, 자동 전사, 데이터 마이닝
도입 형태 On-Premise, 클라우드 기반, 하이브리드
최종 사용자 병원, 임상실, 제약회사, 학술연구기관
기능 정보 추출, 기계 번역, 텍스트 및 음성 처리, 감정 분석

헬스케어 및 생명과학용 자연언어처리(NLP)는 기술 진보와 효율적인 데이터 관리 솔루션에 대한 수요 증가를 배경으로 현저한 시장 점유율 확대를 이루고 있습니다. 경쟁적인 가격 전략과 혁신적인 제품의 지속적인 투입이 시장 특징이며, 이러한 진전은 의료 제공업체의 능력을 강화하고 환자 결과의 개선과 업무 효율화를 실현하고 있습니다. 각 회사는 기존의 의료 시스템과 원활하게 통합되는 NLP 툴의 개발에 주력해, 도입의 용이함과 사용자 체험의 향상을 도모하고 있습니다. NLP 의료 분야경쟁 구도는 기존 기업과 신흥 스타트업의 존재를 특징으로 합니다. 각 회사는 경쟁 우위를 유지하기 위해 연구 개발에 대한 투자를 강화하고 있습니다. 규제의 영향, 특히 북미와 유럽의 규제는 시장 역학을 형성하는 데 매우 중요합니다. 엄격한 규정 준수는 데이터 프라이버시와 보안을 보장하며 NLP 솔루션의 도입률에 영향을 미칩니다. 시장은 성장의 기운에 있으며 AI와 머신러닝 기술의 통합으로 기회가 탄생했습니다. 이러한 진보는 기존의 과제를 해결하고 시장 확대를 추진할 것으로 기대됩니다.

주요 동향과 성장 촉진요인 :

헬스케어 및 생명과학용 자연언어처리 시장은 인공지능과 머신러닝의 진보를 원동력에 급속한 성장을 이루고 있습니다. 주요 동향 중 하나는 임상 문서 관리에 NLP 기술이 통합되어 데이터 관리의 정확성과 효율성이 향상된다는 것입니다. 이 동향은 관리 업무의 효율화와 의료 종사자의 부담 경감의 필요성에 의해 촉진되고 있습니다. 또 다른 중요한 동향은 환자 모니터링 및 맞춤형 의료에서 NLP의 활용입니다. NLP 알고리즘은 환자 데이터를 분석하고 맞춤 치료 계획을 제공함으로써 치료 성과 향상에 기여하고 있습니다. 원격 의료 및 디지털 건강 플랫폼의 상승은 이러한 동향을 더욱 가속화하여 원격 및 실시간으로 환자 정보를 파악할 수 있도록 합니다. 데이터 프라이버시와 보안에 대한 우려는 규제 기준을 준수하는 견고한 NLP 솔루션 개발을 추진하고 있습니다. 의료 데이터의 디지털화가 진행되고 있는 가운데, 기밀성과 완전성의 확보가 최우선 과제가 되고 있습니다. 의료 분야의 예측 분석에 대한 주목도 증가도 또 다른 촉진요인입니다. NLP는 방대한 데이터 세트에서 의미 있는 지식을 추출할 수 있어 질병의 예측과 관리를 지원합니다. 이 능력은 예방적인 의료 전략에 매우 중요합니다. 마지막으로 기술 기업과 의료 제공업체 간의 협력은 자연언어처리 시장의 확대를 촉진하고 있습니다. 이러한 파트너십은 혁신을 키우고 복잡한 의료 과제를 효과적으로 해결하는 최첨단 솔루션의 개발을 추진하고 있습니다.

목차

제1장 주요 요약

제2장 시장 하이라이트

제3장 시장 역학

  • 거시경제 분석
  • 시장 동향
  • 시장 성장 촉진요인
  • 시장 기회
  • 시장 성장 억제요인
  • 연평균 성장률(CAGR) 분석
  • 영향 분석
  • 신흥 시장
  • 기술 로드맵
  • 전략적 프레임워크

제4장 부문 분석

  • 시장 규모 및 예측 : 유형별
    • 규칙 기반 NLP
    • 통계적 NLP
    • 하이브리드 NLP
    • 딥러닝 NLP
  • 시장 규모 및 예측 : 제품별
    • 소프트웨어
    • 플랫폼
    • 도구
    • 애플리케이션
  • 시장 규모 및 예측 : 서비스별
    • 컨설팅
    • 구현
    • 교육
    • 지원 및 유지보수
  • 시장 규모 및 예측 : 기술별
    • 머신러닝
    • 딥러닝
    • 컨텍스트 인식 컴퓨팅
    • 컴퓨터 비전
  • 시장 규모 및 예측 : 구성 요소별
    • 솔루션
    • 서비스
  • 시장 규모 및 예측 : 용도별
    • 임상 문서
    • 컴퓨터 지원 코딩
    • 자동 전사
    • 데이터 마이닝
  • 시장 규모 및 예측 : 배포별
    • On-Premise
    • 클라우드 기반
    • 하이브리드
  • 시장 규모 및 예측 : 최종 사용자별
    • 병원
    • 임상 실험실
    • 제약회사
    • 학술연구기관
  • 시장 규모 및 예측 : 기능별
    • 정보 추출
    • 기계 번역
    • 텍스트 및 음성 처리
    • 감정 분석

제5장 지역별 분석

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 라틴아메리카
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카
  • 아시아태평양
    • 중국
    • 인도
    • 한국
    • 일본
    • 호주
    • 대만
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 스페인
    • 이탈리아
    • 기타 유럽
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 서브 사하라 아프리카
    • 기타 중동 및 아프리카

제6장 시장 전략

  • 수요-공급 격차 분석
  • 무역 및 물류 제약 요인
  • 가격-원가-마진 동향
  • 시장 침투
  • 소비자 분석
  • 규제 현황

제7장 경쟁 정보

  • 시장 포지셔닝
  • 시장 점유율
  • 경쟁 벤치마킹
  • 주요 기업의 전략

제8장 기업 프로파일

  • Nuance Communications
  • IQVIA
  • Health Fidelity
  • Linguamatics
  • SAS Institute
  • Apixio
  • MModal
  • Narrative Dx
  • Lexalytics
  • Averbis
  • Clinithink
  • Deep 6 AI
  • Verantos
  • Enlitic
  • Inovalon
  • Tempus
  • Cortical.io
  • Zebra Medical Vision
  • Flatiron Health
  • Proscia

제9장 회사 소개

KTH 26.03.30

NLP in Healthcare and Life Sciences Market is anticipated to expand from $4.1 billion in 2024 to $39.5 billion by 2034, growing at a CAGR of approximately 27.1%. The NLP in Healthcare and Life Sciences Market encompasses the application of natural language processing technologies to analyze and interpret complex medical data. This includes patient records, clinical trial data, and scientific literature. By enabling more efficient data extraction and insights, NLP enhances decision-making, patient outcomes, and research advancements. Increasing digitalization and the demand for personalized medicine are propelling market growth, fostering innovations in data interoperability and AI-driven diagnostics.

The NLP in Healthcare and Life Sciences Market is expanding rapidly, driven by the need for enhanced data analysis and patient care. The software segment leads, with clinical text mining and EHR data analysis being pivotal for improving healthcare delivery. These applications enable precise patient diagnostics and personalized treatment plans. The services segment follows, particularly in consulting and integration services, reflecting the complexity of adopting NLP technologies in healthcare systems. Clinical applications, such as automated transcription and patient monitoring, are top-performing sub-segments, significantly improving operational efficiency. Drug discovery and genomics analysis are emerging as the second-highest performing sub-segments, driven by the need for accelerated research and development processes. The adoption of NLP for real-time data processing and decision-making is gaining momentum, offering lucrative opportunities for stakeholders. Investments in AI-driven healthcare solutions are increasing, emphasizing the importance of data privacy and regulatory compliance in fostering trust and adoption.

Market Segmentation
TypeRule-Based NLP, Statistical NLP, Hybrid NLP, Deep Learning NLP
ProductSoftware, Platforms, Tools, Applications
ServicesConsulting, Implementation, Training, Support and Maintenance
TechnologyMachine Learning, Deep Learning, Context-Aware Computing, Computer Vision
ComponentSolutions, Services
ApplicationClinical Documentation, Computer-Assisted Coding, Automated Transcription, Data Mining
DeploymentOn-Premises, Cloud-Based, Hybrid
End UserHospitals, Clinical Laboratories, Pharmaceutical Companies, Academic Research Institutes
FunctionalityInformation Extraction, Machine Translation, Text and Voice Processing, Sentiment Analysis

Natural Language Processing (NLP) in Healthcare and Life Sciences is witnessing significant market share growth, driven by technological advancements and the increasing demand for efficient data management solutions. The market is characterized by competitive pricing strategies and the continuous launch of innovative products. These developments are enhancing the capabilities of healthcare providers, enabling improved patient outcomes and operational efficiencies. Companies are focusing on developing NLP tools that integrate seamlessly with existing healthcare systems, ensuring ease of adoption and improved user experience. The competitive landscape in the NLP healthcare sector is marked by the presence of established players and emerging startups. Companies are investing in research and development to maintain a competitive edge. Regulatory influences, particularly in North America and Europe, are pivotal in shaping market dynamics. Compliance with stringent regulations ensures data privacy and security, impacting the adoption rate of NLP solutions. The market is poised for growth, with opportunities arising from the integration of AI and machine learning technologies. These advancements are expected to address existing challenges and drive further market expansion.

Geographical Overview:

The NLP in Healthcare and Life Sciences market is witnessing substantial growth across various regions, each with unique characteristics. North America leads the market, driven by technological advancements and a strong emphasis on improving patient care through AI. The region's robust healthcare infrastructure and significant investments in AI research enhance its market position. Europe follows, with a focus on integrating AI into healthcare systems to enhance efficiency and patient outcomes. The region's commitment to innovation and regulatory support fosters a conducive environment for NLP adoption. In Asia Pacific, rapid technological advancements and increasing healthcare investments propel market expansion. Countries like China and India are emerging as key players due to their large populations and growing healthcare needs. Latin America and the Middle East & Africa present new growth pockets. Latin America benefits from rising investments in healthcare technology, while the Middle East & Africa recognize the potential of NLP in transforming healthcare delivery and improving access to quality care.

The imposition of global tariffs and geopolitical tensions are exerting significant influence on the NLP in Healthcare and Life Sciences Market. Japan and South Korea, reliant on imported NLP technologies, are increasingly investing in domestic AI capabilities to mitigate tariff impacts. China's strategic focus on self-reliance is evident in its accelerated development of indigenous NLP solutions. Taiwan's pivotal role in semiconductor manufacturing remains crucial, though geopolitical risks persist. Globally, the NLP market is experiencing robust growth, driven by AI advancements and increasing healthcare digitization. By 2035, the market is anticipated to flourish, contingent on resilient supply chains and regional collaborations. Concurrently, Middle East conflicts are poised to affect global energy prices, potentially disrupting supply chains and escalating operational costs.

Key Trends and Drivers:

The NLP in Healthcare and Life Sciences Market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning. A key trend is the increasing integration of NLP technologies in clinical documentation, which enhances accuracy and efficiency in data management. This trend is fueled by the need to streamline administrative processes and reduce the burden on healthcare professionals. Another significant trend is the use of NLP in patient monitoring and personalized medicine. NLP algorithms analyze patient data to provide tailored treatment plans, improving patient outcomes. The rise of telemedicine and digital health platforms further accelerates this trend, offering remote and real-time patient insights. Data privacy and security concerns drive the development of robust NLP solutions that comply with regulatory standards. As healthcare data becomes more digitized, ensuring confidentiality and integrity is paramount. The growing focus on predictive analytics in healthcare is another driver. NLP facilitates the extraction of meaningful insights from vast datasets, aiding in disease prediction and management. This capability is crucial for proactive healthcare strategies. Finally, collaborations between tech companies and healthcare providers are expanding the NLP market. These partnerships foster innovation and the development of cutting-edge solutions, addressing complex healthcare challenges effectively.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Deployment
  • 2.8 Key Market Highlights by End User
  • 2.9 Key Market Highlights by Functionality

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Rule-Based NLP
    • 4.1.2 Statistical NLP
    • 4.1.3 Hybrid NLP
    • 4.1.4 Deep Learning NLP
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Software
    • 4.2.2 Platforms
    • 4.2.3 Tools
    • 4.2.4 Applications
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Consulting
    • 4.3.2 Implementation
    • 4.3.3 Training
    • 4.3.4 Support and Maintenance
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Machine Learning
    • 4.4.2 Deep Learning
    • 4.4.3 Context-Aware Computing
    • 4.4.4 Computer Vision
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Solutions
    • 4.5.2 Services
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Clinical Documentation
    • 4.6.2 Computer-Assisted Coding
    • 4.6.3 Automated Transcription
    • 4.6.4 Data Mining
  • 4.7 Market Size & Forecast by Deployment (2020-2035)
    • 4.7.1 On-Premises
    • 4.7.2 Cloud-Based
    • 4.7.3 Hybrid
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Hospitals
    • 4.8.2 Clinical Laboratories
    • 4.8.3 Pharmaceutical Companies
    • 4.8.4 Academic Research Institutes
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Information Extraction
    • 4.9.2 Machine Translation
    • 4.9.3 Text and Voice Processing
    • 4.9.4 Sentiment Analysis

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Deployment
      • 5.2.1.8 End User
      • 5.2.1.9 Functionality
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Deployment
      • 5.2.2.8 End User
      • 5.2.2.9 Functionality
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Deployment
      • 5.2.3.8 End User
      • 5.2.3.9 Functionality
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Deployment
      • 5.3.1.8 End User
      • 5.3.1.9 Functionality
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Deployment
      • 5.3.2.8 End User
      • 5.3.2.9 Functionality
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Deployment
      • 5.3.3.8 End User
      • 5.3.3.9 Functionality
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Deployment
      • 5.4.1.8 End User
      • 5.4.1.9 Functionality
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Deployment
      • 5.4.2.8 End User
      • 5.4.2.9 Functionality
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Deployment
      • 5.4.3.8 End User
      • 5.4.3.9 Functionality
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Deployment
      • 5.4.4.8 End User
      • 5.4.4.9 Functionality
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Deployment
      • 5.4.5.8 End User
      • 5.4.5.9 Functionality
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Deployment
      • 5.4.6.8 End User
      • 5.4.6.9 Functionality
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Deployment
      • 5.4.7.8 End User
      • 5.4.7.9 Functionality
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Deployment
      • 5.5.1.8 End User
      • 5.5.1.9 Functionality
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Deployment
      • 5.5.2.8 End User
      • 5.5.2.9 Functionality
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Deployment
      • 5.5.3.8 End User
      • 5.5.3.9 Functionality
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Deployment
      • 5.5.4.8 End User
      • 5.5.4.9 Functionality
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Deployment
      • 5.5.5.8 End User
      • 5.5.5.9 Functionality
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Deployment
      • 5.5.6.8 End User
      • 5.5.6.9 Functionality
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Deployment
      • 5.6.1.8 End User
      • 5.6.1.9 Functionality
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Deployment
      • 5.6.2.8 End User
      • 5.6.2.9 Functionality
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Deployment
      • 5.6.3.8 End User
      • 5.6.3.9 Functionality
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Deployment
      • 5.6.4.8 End User
      • 5.6.4.9 Functionality
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Deployment
      • 5.6.5.8 End User
      • 5.6.5.9 Functionality

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Nuance Communications
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 IQVIA
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Health Fidelity
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Linguamatics
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 SAS Institute
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Apixio
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 MModal
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Narrative Dx
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Lexalytics
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Averbis
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Clinithink
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Deep 6 AI
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Verantos
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Enlitic
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Inovalon
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Tempus
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Cortical.io
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Zebra Medical Vision
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Flatiron Health
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Proscia
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제